Under the deal, Globus Medical (NYSE:GMED) will buy all of Nevro's (NVRO) stock for $5.85 per share in cash. The price ...

Globus Medical GMED has entered into a definitive agreement to acquire Nevro Corp. NVRO in an all-cash transaction valued at approximately $250 million. Under the terms of the agreement ...

On Thursday, Stifel analysts maintained a Buy rating and a $92.00 price target for Globus Medical (NYSE:GMED) stock following ...

Nevro NVRO shares ended the last trading session ... One other stock in the same industry, Globus Medical GMED, finished the last trading session 2% higher at $78.59. GMED has returned 4.3% ...

Nevro Corp. NVRO is well-poised for growth in the coming ... has an estimated long-term growth rate of 11.2%. GMED’s earnings surpassed estimates in three of the trailing four quarters and ...

The bank also raised Globus Medical (GMED) overweight from equal weight and ... Morgan Stanley added that it had become more cautious on Nevro (NVRO) “despite trading at all-time lows as we ...

Investors in Nevro Corp (Symbol: NVRO) saw new options begin trading this week, for the March 17th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the NVRO ...

Globus Medical (NYSE:GMED) said it has agreed to buy Nevro (NVRO) through an all-cash deal with an equity value of around $250M. Under the deal, Globus Medical (NYSE:GMED) will buy all of Nevro's ...

On Thursday, Stifel analysts maintained a Buy rating and a $92.00 price target for Globus Medical (NYSE: GMED) stock following the company’s announcement of acquiring Nevro Corp . (NYSE: NVRO) for an ...

Nevro NVRO shares ended the last trading session 5.1% higher at $39.04. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the session. This compares ...